ZDOCK and RDOCK performance in CAPRI rounds 3, 4, and 5. Proteins

Bioinformatics Program, Boston University, Boston, Massachusetts 02215, USA.
Proteins Structure Function and Bioinformatics (Impact Factor: 2.63). 08/2005; 60(2):207-13. DOI: 10.1002/prot.20559
Source: PubMed


We present an evaluation of the results of our ZDOCK and RDOCK algorithms in Rounds 3, 4, and 5 of the protein docking challenge CAPRI. ZDOCK is a Fast Fourier Transform (FFT)-based, initial-stage rigid-body docking algorithm, and RDOCK is an energy minimization algorithm for refining and reranking ZDOCK results. Of the 9 targets for which we submitted predictions, we attained at least acceptable accuracy for 7, at least medium accuracy for 6, and high accuracy for 3. These results are evidence that ZDOCK in combination with RDOCK is capable of making accurate predictions on a diverse set of protein complexes.

1 Follower
30 Reads
  • Source
    • "The 3D structure of CD147 monomer (3B5H, chain C) was then docked to the Fv model of metuximab using the program ZDOCK with framework region blocked [27]. The results were evaluated using ZRANK and optimized using RDOCK [28] [29]. The top one docking model from RDOCK was picked up as the theoretical metuximab-CD147 complex. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Metuximab is the generic name of Licartin, a new drug for radioimmunotherapy of hepatocellular carcinoma. Although it is known to be a mouse monoclonal antibody against CD147, the complete epitope mediating the binding of metuximab to CD147 remains unknown. We panned the Ph.D.-12 phage display peptide library against metuximab and got six mimotopes. The following bioinformatics analysis based on mimotopes suggested that metuximab recognizes a conformational epitope composed of more than 20 residues. The residues of its epitope may include T28, V30, K36, L38, K57, F74, D77, S78, D79, D80, Q81, G83, S86, N98, Q100, L101, H102, G103, P104, V131, P132, and K191. The homology modeling of metuximab and the docking of CD147 to metuximab were also performed. Based on the top one docking model, the epitope was predicted to contain 28 residues: AGTVFTTV (23-30), I37, D45, E84, V88, EPMGTANIQLH (92-102), VPP (131-133), Q164, and K191. Almost half of the residues predicted on the basis of mimotope analysis also appear in the docking result, indicating that both results are reliable. As the predicted epitopes of metuximab largely overlap with interfaces of CD147-CD147 interactions, a structural mechanism of metuximab is proposed as blocking the formation of CD147 dimer.
    Computational and Mathematical Methods in Medicine 06/2013; 2013(2):983829. DOI:10.1155/2013/983829 · 0.77 Impact Factor
  • Source
    • "The obtained optimized structure of X12 was used for the following docking. Docked conformation and interaction energies were obtained using the docking program ZDOCK [30]. The free energies were calculated based on shape complementarity as type of correlation using a default grid spacing of 2.0 Å. "
    [Show abstract] [Hide abstract]
    ABSTRACT: N-α-acetyltransferase 10 protein (Naa10p) regulates various pathways associated with cancer cell proliferation, metastasis, apoptosis and autophagy. However, its role in protein quality control is unknown. Here, we report that Naa10p is physically associated with proteasome activator 28β (PA28β). Naa10p also interacts with PA28α in a PA28β-dependent manner. Naa10p negatively regulates PA28-dependent chymotrypsin-like proteasome activity in cancer cells and in a cell-free system reconstituted with purified proteins, which was not related to 26S proteasome. Acetyltransferase activity of Naa10p isn't required for its effect on chymotrypsin-like proteasome activity. Therefore, our data reveal that Naa10p suppresses 28S proteasome activity through interaction with PA28β. STRUCTURED SUMMARY OF PROTEIN INTERACTIONS: Naa10pphysically interactswithPS28alphaandPS28 betabyanti bait coimmunoprecipitation(View Interaction:1,2).
    FEBS letters 04/2013; 587(11). DOI:10.1016/j.febslet.2013.04.016 · 3.17 Impact Factor
  • Source
    • "Peptides were docked using the ZDOCKpro program (Accelrys, San Diego, CA) (Chen et al., 2003; Li et al., 2003) consisting of a two-phase docking procedure. The ZDOCK/RDOCK method has been validated by multiple independent protein-protein docking studies and has been found to be a reliable method for the prediction of protein-protein interactions (Wiehe et al., 2005). The program ZDOCK initially identifies the docking positions possible within the receptor for the peptides based on shape, steric, and electrostatic complementarities. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Neuronal nicotinic acetylcholine receptor (nAChR) signaling has been implicated in a variety of normal central nervous system (CNS) functions as well as an array of neuropathologies. Previous studies have demonstrated both neurotoxic and neuroprotective actions of peptides derived from apolipoprotein E (apoE). It has been discovered that apoE-derived peptides inhibit native and recombinant alpha7-containing nAChRs, indicating a direct interaction between apoE peptides and nAChRs. To probe the structure/function interaction between alpha7 nAChRs and the apoE peptide apoE(141-148), experiments were conducted in Xenopus laevis oocytes expressing wild-type and mutated nAChRs. Mutation of Trp55 to alanine blocks apoE peptide-induced inhibition of acetylcholine (ACh)-mediated alpha7 nAChR responses. Additional mutations at Trp55 suggest that hydrophobic interactions between the receptor and apoE(141-148) are essential for inhibition of alpha7 nAChR function. A mutated apoE peptide also demonstrated decreased inhibition at alpha7-W55A nAChRs as well as activity-dependent inhibition of both wild-type alpha7 nAChRs and alpha7-W55A receptors. Finally, a three-dimensional model of the alpha7 nAChR was developed based on the recently refined Torpedo marmorata nACh receptor. A structural model is proposed for the binding of apoE(141-148) to the alpha7 nAChR where the peptide binds at the interface between two subunits, near the ACh binding site. Similar to the functional data, the computational docking suggests the importance of hydrophobic interactions between the alpha7 nAChR and the apoE peptide for inhibition of receptor function. The current data suggest a mode for apoE peptide binding that directly blocks alpha7 nAChR activity and consequently may disrupt nAChR signaling.
    Molecular Pharmacology 11/2007; 72(4):838-49. DOI:10.1124/mol.107.035527 · 4.13 Impact Factor
Show more

Preview (2 Sources)

30 Reads
Available from